Replies to post #51394 on Ocata Therapeutics Inc fka OCAT

[SPM555]

Some interesting action today, I think there's a good chance this marks the end of the 2 month pullback, though we'll need confirmation of that next week in the form of follow through and the price getting back above the 50 day moving average. News would certainly help that cause.

[lasers]

The Big News coming is that the DSMB declares that the Cohort2 100K for both SMD and DAMD trial are safe and successful.

This news then allows

(i)Cohort2a to begin with 4 patients for their 100K efficacy trial

(ii) Cohort3 for both DAMD and SMD, with 3 patients each, to begin the 150K treatment.

The DSMB approval is expected in the next 2 weeks and hopefully next week as ACT is all set to go.

#####

Clinical trials SMD & DAMD

SMD

http://clinicaltrials.gov/show/NCT01345006

DAMD
http://www.clinicaltrials.gov/ct2/show/NCT01344993?term=dry+amd&rank=1